Published in Am J Ophthalmol on July 15, 1986
A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology (2001) 5.16
Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol (1996) 2.48
Surgical approaches to the orbit. Indications and techniques. J Neurosurg (1984) 1.89
The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology (1997) 1.63
Diagnostic value and limitations of orbital biopsy in Wegener's granulomatosis. Ophthalmology (1992) 1.62
The role of postoperative irradiation in the management of sphenoid wing meningiomas. A preliminary report. Ophthalmology (1996) 1.62
The frequency of perioperative vision loss. Anesth Analg (2001) 1.57
The nonspecific orbital inflammatory syndromes. Surv Ophthalmol (1985) 1.55
The treatment of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol (1996) 1.49
Serum antibody production to botulinum A toxin. Ophthalmology (1993) 1.49
Sarcoid masquerading as optic nerve sheath meningioma. Mayo Clin Proc (1997) 1.44
Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease. Mayo Clin Proc (1993) 1.39
Traumatic carotid artery dissection causing blindness. Mayo Clin Proc (2000) 1.38
Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol (2001) 1.31
Orbital apex syndrome secondary to herpes zoster ophthalmicus. Am J Ophthalmol (1978) 1.31
Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography. Arch Ophthalmol (1981) 1.30
Chronology of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol (1996) 1.29
Idiopathic intracranial hypertension. Mayo Clin Proc (1994) 1.28
Risk factors for ischemic optic neuropathy after cardiopulmonary bypass: a matched case/control study. Anesth Analg (2001) 1.26
Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol (2001) 1.26
Cemento-ossifying fibroma of the ethmoidal sinus manifesting as proptosis. Ann Ophthalmol (1982) 1.25
Evaluation of orbital cellulitis and results of treatment. Laryngoscope (1982) 1.17
Recurrent spheno-orbital meningioma. J Neurosurg (1994) 1.15
Orbital fine-needle aspiration biopsy. Am J Ophthalmol (1985) 1.13
Electroretinographic responses following vitamin A therapy in A-beta-lipoproteinemia. Am J Ophthalmol (1972) 1.12
Ocular complications of atopic dermatitis. Can J Ophthalmol (1984) 1.12
Orbital exenteration at the Mayo Clinic. 1967-1986. Ophthalmology (1989) 1.11
The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol (1995) 1.09
An orbital decompression for severe dysthyroid exophthalmos. Ophthalmology (1982) 1.08
Graves' ophthalmopathy in childhood and adolescence. Arch Ophthalmol (1980) 1.05
Long-term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmology (1996) 1.05
A review of 340 orbital tumors in children during a 60-year period. Am J Ophthalmol (1994) 1.04
Medial rectus injury from intranasal surgery. Arch Ophthalmol (1979) 1.03
Stereotactic radiosurgery and particulate embolization for cavernous sinus dural arteriovenous fistulae. Neurosurgery (1999) 1.02
Massive epithelium-lined inclusion cysts after scleral buckling. Am J Ophthalmol (1992) 1.01
Lacrimal bypass surgery in patients with sarcoidosis. Am J Ophthalmol (1999) 1.01
Spindle cell lipoma of the orbit. Am J Ophthalmol (1985) 1.01
Ocular motor nerve palsies in spontaneous dissections of the cervical internal carotid artery. Neurology (1993) 0.99
Optic nerve/sheath enlargement. A differential approach based on high-resolution CT morphology. Radiology (1984) 0.99
Surgery for orbital tumors. Part II: transorbital approaches. Neurosurg Focus (2001) 0.98
Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol (1988) 0.98
Orbital amyloidosis involving the extraocular muscles. Arch Ophthalmol (1989) 0.98
Intrasellar mucocele simulating pituitary adenoma: case report. Neurosurgery (1986) 0.97
An eyelash nidus for dacryoliths of the lacrimal excretory and secretory systems. Am J Ophthalmol (1991) 0.95
Extraocular muscle surgery for dysthyroid myopathy. Am J Ophthalmol (1983) 0.95
Clinical course of an incompletely removed cavernous hemangioma of the orbit. Ophthalmology (1990) 0.95
Pneumosinus Dilatans, Klippel-Trenaunay-Weber syndrome, and progressive visual loss. Ann Ophthalmol (1981) 0.95
Surgical management of nasolacrimal duct obstruction in patients with Wegener's granulomatosis. Ophthalmology (1992) 0.95
Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicity. Cancer Invest (1990) 0.93
Cryosurgery re-visited for the removal and destruction of brain, spinal and orbital tumours. Neurol Res (1992) 0.93
Vitreous cellular reaction. Association with reticulum cell sarcoma of brain. Arch Ophthalmol (1975) 0.93
Optic nerve sheath meningiomas. Clinical manifestations. Ophthalmology (1984) 0.93
The differential diagnosis of orbital calcification as detected on computed tomographic scans. Mayo Clin Proc (1993) 0.92
Primary idiopathic inflammation of the optic nerve. Am J Ophthalmol (1982) 0.92
Extensive defects of the sino-orbital region. Results with microvascular reconstruction. Arch Otolaryngol Head Neck Surg (1992) 0.92
CT-guided fine needle aspiration biopsy of orbital optic nerve tumors. Ophthalmology (1980) 0.91
Serum antibodies reactive with eye muscle membrane antigens are detected in patients with nonspecific orbital inflammation. Ophthalmology (1995) 0.91
Surgical management of orbital lymphangioma with the carbon dioxide laser. Am J Ophthalmol (1986) 0.91
Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients. Clin Immunol Immunopathol (1998) 0.91
Combined clinical and computed tomographic diagnosis of orbital glioma and meningioma. Ophthalmology (1984) 0.91
Treatment of dysthyroid lower lid retraction with autogenous tarsus transplants. Ophthal Plast Reconstr Surg (1992) 0.89
Radical orbital decompression for severe dysthyroid exophthalmos. J Neurosurg (1982) 0.89
Fine needle aspiration biopsy of metastatic orbital tumors. Surv Ophthalmol (1983) 0.88
Thyroid carcinoma metastatic to the globe. Br J Ophthalmol (1979) 0.88
Radiation treatment of orbital lymphoid hyperplasia. Ophthalmology (1979) 0.87
Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment. Int J Radiat Oncol Biol Phys (1991) 0.87
Cryptococcal endophthalmitis and meningitis associated with acute psychosis and exudative retinal detachment. Am J Ophthalmol (1987) 0.87
Refractory idiopathic intracranial hypertension treated with stereotactically planned ventriculoperitoneal shunt placement. Neurosurg Focus (2001) 0.86
The role of second-intention healing in periocular reconstruction. Ophthal Plast Reconstr Surg (1997) 0.86
Clinical review 13: Diagnosis and management of Graves' ophthalmopathy. J Clin Endocrinol Metab (1990) 0.86
Graves ophthalmopathy. Results of transantral orbital decompression performed primarily for cosmetic indications. Ophthalmology (1994) 0.85
Orbital lymphangioma. Correlation of magnetic resonance images and intraoperative findings. Ophthalmology (1992) 0.85
The clinical spectrum of schwannomas presenting with visual dysfunction: a clinicopathologic study of three cases. Surv Ophthalmol (1999) 0.85
Preoperative evaluation of the juvenile cataract. Int Ophthalmol Clin (1977) 0.85
Eye care for patients receiving neuromuscular blocking agents or propofol during mechanical ventilation. Am J Crit Care (2000) 0.85
Acute and subacute orbital myositis. Am J Ophthalmol (1983) 0.84
Microsurgical removal of a primary intraorbital meningioma. Am J Ophthalmol (1978) 0.84
Evaluation of eyes with opaque anterior segments, using both ultrasonography and electroretinography. Am J Ophthalmol (1973) 0.83
A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin. Autoimmunity (1999) 0.83
Liposarcoma of the orbit: a management challenge. Ophthal Plast Reconstr Surg (1998) 0.83
Neurofibromatosis type 1 with bilateral acoustic neuromas. Neurofibromatosis (1989) 0.83
Transantral-ethmoidal decompression of optic canal fracture. Arch Ophthalmol (1976) 0.83
Orbital aspergillosis. Report of a case diagnosed by fine needle aspiration biopsy. Acta Cytol (1983) 0.82
Orbital metastasis of bladder carcinoma. Am J Ophthalmol (1982) 0.82
Cyclophosphamide in the treatment of orbital vasculitis. Am J Ophthalmol (1986) 0.82
Fine needle aspiration diagnosis of orbital plasmacytoma with amyloidosis. A case report. Acta Cytol (1995) 0.82
Juvenile fibromatosis of the orbit: a case report with review of the literature. Br J Ophthalmol (1991) 0.82
Fine-needle aspiration for the diagnosis of primary epithelial tumors of the lacrimal gland and ocular adnexa. Diagn Cytopathol (2001) 0.81
Orbital fine needle aspiration biopsy with B-scan guidance. Am J Ophthalmol (1980) 0.81
B-scan ultrasonic evaluation of a dilated superior ophthalmic vein in orbital and retro-orbital arteriovenous anomalies. J Clin Neuroophthalmol (1983) 0.81
Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction. J Endocrinol Invest (1996) 0.81
Computed tomographic diagnosis of suprasellar masses by intrathecal enhancement. Radiology (1977) 0.81
Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy. Thyroid (1998) 0.81
Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy. Mayo Clin Proc (1994) 0.81
Refractory periorbital edema in a 29-year-old man. Ann Allergy (1992) 0.81
Orbital venous anomalies. A long-standing dilemma. Ophthalmology (1997) 0.80
Fine-needle aspiration for the diagnosis of orbital hematolymphoid lesions. Diagn Cytopathol (2000) 0.80
Visual loss as a result of primary optic nerve neuropathy after intranasal corticosteroid injection. Am J Ophthalmol (1980) 0.80